D
KalVista Pharmaceuticals, Inc. KALV
$13.21 -$0.42-3.08% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2025 01/31/2025 10/31/2024 07/31/2024 04/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 15.89M 12.59M 16.61M 26.61M 25.25M
Gross Profit -15.89M -12.59M -16.61M -26.61M -25.25M
SG&A Expenses 39.14M 30.35M 29.20M 17.60M 23.21M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 55.03M 42.94M 45.81M 44.22M 48.46M
Operating Income -55.03M -42.94M -45.81M -44.22M -48.46M
Income Before Tax -53.08M -44.26M -42.27M -40.44M -44.65M
Income Tax Expenses -855.00K 4.25M -- -- --
Earnings from Continuing Operations -52.23M -48.51M -42.27M -40.44M -44.65M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -52.23M -48.51M -42.27M -40.44M -44.65M
EBIT -55.03M -42.94M -45.81M -44.22M -48.46M
EBITDA -54.77M -42.71M -45.58M -43.99M -48.24M
EPS Basic -0.98 -0.92 -0.91 -0.87 -1.02
Normalized Basic EPS -0.63 -0.53 -0.57 -0.55 -0.64
EPS Diluted -0.98 -0.92 -0.91 -0.87 -1.02
Normalized Diluted EPS -0.63 -0.53 -0.57 -0.55 -0.64
Average Basic Shares Outstanding 53.04M 52.64M 46.70M 46.23M 43.59M
Average Diluted Shares Outstanding 53.04M 52.64M 46.70M 46.23M 43.59M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --